Taguchi, Nao
Piao, Yi
Rubino, Annalisa
Lee, KuanYeh
Chen, Megan
Harada, Keisuke
Tanikawa, Tetsuya
Naito, Toshio
Funding for this research was provided by:
Gilead Sciences, K.K.
Article History
Received: 22 December 2023
Accepted: 16 July 2024
First Online: 22 July 2024
Competing interests
: NT, YP, AR, KL, MC, KH and TT are Gilead employees and stockholders. TN has received research grants from Gilead Sciences, consulting fees from Nobelpharma Co., Ltd., and TSUMURA & CO., and he has received lecture fees from MSD K.K., ViiV Healthcare and Gilead Sciences.